Li F - Search Results

1

Lymphotactin expression by engineered myeloma cells drives tumor regression: mediation by CD4+ and CD8+ T cells and neutrophils expressing XCR1 receptor.

Cairns CM, Gordon JR, Li F, Baca-Estrada ME, Moyana T, Xiang J. Cairns CM, et al. Among authors: li f. J Immunol. 2001 Jul 1;167(1):57-65. doi: 10.4049/jimmunol.167.1.57. J Immunol. 2001. PMID: 11418632

2

Synergistic enhancement of antitumor immunity with adoptively transferred tumor-specific CD4+ and CD8+ T cells and intratumoral lymphotactin transgene expression.

Huang H, Li F, Gordon JR, Xiang J. Huang H, et al. Among authors: li f. Cancer Res. 2002 Apr 1;62(7):2043-51. Cancer Res. 2002. PMID: 11929823

3

Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha.

Zhang W, Chen Z, Li F, Kamencic H, Juurlink B, Gordon JR, Xiang J. Zhang W, et al. Among authors: li f. Immunology. 2003 Feb;108(2):177-88. doi: 10.1046/j.1365-2567.2003.01489.x. Immunology. 2003. PMID: 12562326 Free PMC article.

4

CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma.

Gordon JR, Li F, Nayyar A, Xiang J, Zhang X. Gordon JR, et al. Among authors: li f. J Immunol. 2005 Aug 1;175(3):1516-22. doi: 10.4049/jimmunol.175.3.1516. J Immunol. 2005. PMID: 16034089

5

ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.

Zhao X, Town JR, Li F, Zhang X, Cockcroft DW, Gordon JR. Zhao X, et al. Among authors: li f. J Immunol. 2009 Mar 1;182(5):3213-22. doi: 10.4049/jimmunol.0800551. J Immunol. 2009. PMID: 19234219

6

Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin.

Huang H, Li F, Cairns CM, Gordon JR, Xiang J. Huang H, et al. Among authors: li f. Biochem Biophys Res Commun. 2001 Feb 23;281(2):378-82. doi: 10.1006/bbrc.2001.4363. Biochem Biophys Res Commun. 2001. PMID: 11181058

7

CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.

Li F, Zhang X, Gordon JR. Li F, et al. Biochem Biophys Res Commun. 2002 May 10;293(3):939-44. doi: 10.1016/S0006-291X(02)00318-2. Biochem Biophys Res Commun. 2002. PMID: 12051749

8

CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo.

Li F, Zhang X, Mizzi C, Gordon JR. Li F, et al. Vet Immunol Immunopathol. 2002 Nov;90(1-2):65-77. doi: 10.1016/s0165-2427(02)00223-4. Vet Immunol Immunopathol. 2002. PMID: 12406656 Clinical Trial.

9

Engineered fusion hybrid vaccine of IL-18 gene-modified tumor cells and dendritic cells induces enhanced antitumor immunity.

Xia D, Li F, Xiang J. Xia D, et al. Among authors: li f. Cancer Biother Radiopharm. 2004 Jun;19(3):322-30. doi: 10.1089/1084978041424990. Cancer Biother Radiopharm. 2004. PMID: 15285878

10

Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma.

Liu Y, Xia D, Li F, Zheng C, Xiang J. Liu Y, et al. Among authors: li f. Cancer Gene Ther. 2005 Feb;12(2):122-32. doi: 10.1038/sj.cgt.7700757. Cancer Gene Ther. 2005. PMID: 15565183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,967 results

Search Page

Filters